| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 165,263 | 99,257 | 667,141 | 143,127 | | Cost of Revenue | 58,351 | 66,547 | 67,350 | 66,903 | | | Gross Profit |
-
| 32,710 | 599,791 | 76,224 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 209,755 | 128,968 | 182,669 | 159,783 | | Non Recurring | (42,850) | 25,608 | 17,242 | (29,799) | | Others | 57,468 | (80,224) | 432,176 | 217,556 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (41,642) | (32,296) | (271,316) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (117,461) | (41,642) | (32,296) | (271,316) | | Interest Expense | 61,163 | 61,284 | 60,898 | 64,653 | | Income Before Tax | (178,624) | (102,926) | (93,194) | (335,969) | | Income Tax Expense | 114,965 | (31,261) | (28,696) | (117,506) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (293,589) | (71,665) | (64,498) | (218,463) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (293,589) | (71,665) | (64,498) | (218,463) | | Preferred Stock And Other Adjustments | (4,623) | (4,922) | (2,919) |
-
| | | Net Income Applicable To Common Shares | ($298,212) | ($76,587) | ($67,417) | ($218,463) |
|
0.31% Nasdaq 
0.05%
Income Statement
